Eventual change in the dissolution characteristics of some dosage forms, which is ascribed to cross-linking of gelatin, continues to present challenges to drug manufacturers. The authors discuss the causes, mechanisms, and solutions to the problem.
K. Venugopal
Advertisement
K. Venugopal is a postgraduate student from the National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar 160 062, India, presently working at Ranbaxy Research Laboratories (Gurgaon, India).
Articles by K. Venugopal
Advertisement
Latest Updated Articles
- Alteration in Dissolution Characteristics of Gelatin-Containing Formulations: A Review of the Problem, Test Methods, and Solutions
Published: April 1st 2002 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
